MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression.

[1]  Shu Liu,et al.  Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. , 2010, Genes & development.

[2]  Jaw-Yuan Wang,et al.  MMP13 is a potential prognostic marker for colorectal cancer. , 2010, Oncology reports.

[3]  Y. Okada,et al.  Expression Profiles and Clinical Correlations of Degradome Components in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma , 2010, Clinical Cancer Research.

[4]  Robert A. Weinberg,et al.  Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.

[5]  Yusuke Yamamoto,et al.  Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  N. Sugimoto,et al.  In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential , 2009, Journal of cellular biochemistry.

[7]  Hiroshi I. Suzuki,et al.  Modulation of microRNA processing by p53 , 2009, Nature.

[8]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[9]  H. Tsai,et al.  Labeled microRNA pull-down assay system: an experimental approach for high-throughput identification of microRNA-target mRNAs , 2009, Nucleic acids research.

[10]  X. Chen,et al.  Role of miR-143 targeting KRAS in colorectal tumorigenesis , 2009, Oncogene.

[11]  G. Nuovo,et al.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. , 2008, Biochemical and biophysical research communications.

[12]  A. Donfrancesco,et al.  Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM , 2008, PloS one.

[13]  Heidi J. Peltier,et al.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. , 2008, RNA.

[14]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[15]  Martina Olivero,et al.  A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging , 2008, PloS one.

[16]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[17]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[18]  T. Ochiya,et al.  MicroRNAs as biomarkers and therapeutic drugs in human cancer. , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[19]  Yukio Kitade,et al.  Downregulation of microRNAs‐143 and ‐145 in B‐cell malignancies , 2007, Cancer science.

[20]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[21]  Naoto Tsuchiya,et al.  Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells , 2007, Proceedings of the National Academy of Sciences.

[22]  W. Cho.  OncomiRs: the discovery and progress of microRNAs in cancers , 2007, Molecular Cancer.

[23]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[24]  A. Fire,et al.  Patterns of known and novel small RNAs in human cervical cancer. , 2007, Cancer research.

[25]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[26]  Shuomin Zhu,et al.  miR-21-mediated tumor growth , 2007, Oncogene.

[27]  C. Croce,et al.  MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.

[28]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[29]  J. Ko,et al.  Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer. , 2006, Lung cancer.

[30]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[32]  F. Vizoso,et al.  Collagenase-3 (MMP-13) Expression in Cutaneous Malignant Melanoma , 2005, The International journal of biological markers.

[33]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Ochiya,et al.  Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[36]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[37]  A. Montag,et al.  An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis , 2005, Clinical & Experimental Metastasis.

[38]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[39]  S. Tatebe,et al.  Anti-Fas antibody-induced apoptosis in human colorectal carcinoma cell lines: role of the p53 gene , 1998, Apoptosis.

[40]  D. Jenkins,et al.  Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis , 2004, Clinical & Experimental Metastasis.

[41]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[42]  A. Goorin,et al.  Current Treatment of Osteosarcoma , 2001, Cancer investigation.

[43]  S. Ferrari,et al.  Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  B. Reinhart,et al.  Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA , 2000, Nature.

[45]  N. Jaffe,et al.  Osteosarcoma in Preadolescent Patients , 2000, Clinical Orthopaedics and Related Research.

[46]  T. Ochiya,et al.  New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet , 1999, Nature Medicine.

[47]  A. Huvos,et al.  Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  B. Czerniak,et al.  Bone cancers , 1995, Cancer.

[49]  W. Akeson,et al.  Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. , 1993, Cancer research.

[50]  G. Humphrey,et al.  Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies , 1993 .

[51]  M. Link.  Commentary on the use of presurgical chemotherapy , 1993 .

[52]  M. Link.  Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy. , 1993, Cancer treatment and research.